Member Info for Trickymatters

I had a day out with my family today. When I left this morning the sp was 54.5p. So that's a very nice surprise to come home to! Looks like we are on our way then.

I think that might have had something to do with the sp on reflection. Nothing to do with us but it will raise questions about wtf Han**** is doing and whether he can deliver a mass testing program.
If anything more likely we will get a massive order. We can deliver which most of the companies listed are in no position to do. Probably some bloody Cummings charade.

Just had a look at the peer reviewed papers for this new test that was mentioned as a potential option- amongst the 100 providers that government are looking at, but it was name checked under 'background notes'. Papers are published between August 28th and 31st. The tests have hardly been independently tested- clinical groups of 40. They were designed for nasal swabs and were planning adaptations for saliva. Poor levels of accuracy-92% most recently. The big advantage is sold on ease of use. I am at a loss why we are spending time on this. Clearly way behind ODX and Mologic and not meeting MHRA standards.
I am wondering about this government tbh. They can't seem to just keep to the rules and get the job done. Always has to be a drama. Oh well. We will get there soon enough.

Yeah true Chapsville. We could sell shares in him if their were a market for misanthropy.
Dd, if you buy on a spike then you have to wait for the big news that tempted you to buy in. That's how investment works. So I'm on a perfectly respectable profit so I feel fine. But if I bought high then I wait. Don't deramp your own investment. No-one is remotely influenced by you anyway but it makes you look like a plonker.

DubleD, you're the only one getting on a few nerves. Whether we are up or down you're always the Merchant of Double Deep depression. See a doctor or reconsider your decision to be an investor.

Pressure is mounting again. Looking forward to next week. Have a good weekend everyone.

Honestly Hants mate, I don't think you are invested. I have shared loads of published research and reports covering them as they were published in real time. I can't be bothered with time wasters. Sorry. Am on this board to talk to investors.

TCO, I bet Acacia's shareholders are kicking them too!

Old news Hants. Small studies. Out of date. There isn't just 1 antibody that confers immunity. There are several. Our tests all measure more than one. It's complex. The T cells play a role too. Why have you invested if you are so out of date? If you are not invested get off this board. You are wasting our time.

Hants, Antibodies show if you have had the virus past tense and if you have it now. Antigens only show if you have it now so they don't track total prevalence only active prevalence. Once you have had it you are extremely unlikely to get it again. They have found 3/26 million who have had it twice and second infection for those 3 was asymptomatic. So the scientific consensus is that it's extremely likely that you have immunity for at least 6 months- because that's thetimeframe they have been measuring it probably at least a year and possibly many years even decades. Numerous studies worldwide. Iceland is the most recent big study. We are now looking at this with 100,000 health workers. The study started in July and was extended for a larger cohort on August 24th.

That must be why you are a novice investor then. Why are you here by the way? Are you invested? If not, thanks for your wise words but...

He's emphasising downside risks as more probable. We may not have a vaccine that's widely shared for 3 years.
Test, test, test. And make it easy for everyone.

Strong buy. Goes without saying. Acacia sold out of SNG at 34p as we have been reminded already by steadyeddy. Our trials enabling MHRA approval are in the final stages. The government have been messy in response to the virus. But they are absolutely determined/desperate to get us back to work and back to engaging in all parts of life. They have now outlined a trial to test the value of mass, repeat testing. They want accurate, cheap, accessible tests which are easy to process. We have 3 poc tests which meet these standards (as well as lab tests). Two are antibody and one antigen. We can produce more or less of any according to demand. Everything has to be properly validated before they will name names because they are not going to make the same mistakes again about buying before the evidence is in. We are further ahead than any other new players as far as we know.
We can always take the opportunity to buy now that this is so de-risked.

Check out the story in the Herald today. Omega are launching the Mologic antibody test this month for sale to pharmacies and GPs.

Keep your eyes on the prize guys and gals. Looks like a tree shake going on. Ulster assessment will confirm 99.4% specificity and 98% sensitivity. Best antibody poc test in the world. Low cost, accessible, linked to an app. Perfect to complement the mass testing program to ensure 100% tracking and understanding prevalence to get confidence back in the economy.

Totally agree unvrkw. Poc will be the only tests to last the pace. Both antibody and antigen. I also think the idea that 60 million people will send their results in to labs won't stand up. It will have to be kits that are linked to an app so the results can be sent in electronically. Serious implications for cybersecurity though.

The 500 million is just for trials for proof of concept. Some of the new antigen tests are also being compared- lots not just 2. The point is that this is to explore whether rapid tests will work in this context. There's a £10 billion pound budget for test and trace already set aside in the budget.
The RTC will be in the mix and so will anything else that meets the higher MHRA guidance. I would put money on it. Oh yeah. I already have. :)

Dated June 22nd. Shows the research plan and this press release does list some firms. It also says they are in addition talking to 'leading manufacturers from the (diagnostics?) industry' to help scale up production. They are talking about producing 60 million tests a week. Anyone who can deliver is going to be in this. No way they won't use other credible devices. We have had plenty of proof that the competition can't always really deliver.

It doesn't mention which tests they are using for the trials which are about proof of concept. One is a saliva test and one is a 'rapid 20 minute test'. We don't even know if they are antigen or antibody yet.

The hope is that weekly tests for the whole population will help us manage and suppress the virus. This is amazing news. Every test that meets the MHRA new guidance will be used if this comes off. Trials in Southampton and Salford will test the concept. I can't believe the negativity on this board. It's offputting for new investors. Trolls like Tree are simply spouting utter nonsense to confuse people. And there's at least one other normally solid contributor who has admitted he was trading for a few per cent a day and then decided to stop- now complaining already. Your prerogative but stop ****ging off the company.
Manufacturing of these devices is itself a highly specialised knowledge base. That's why Roche and Abbott fell down. We have a massive opportunity here. Once in a lifetime. All we have to do is keep it together and promote this firm by sharing information and staying up to date with progress.
If you can't do that then just sell and go somewhere else if you think you can do better elsewhere. I very much doubt there's a better deal in the next few weeks that can be so obviously anticipated anywhere on the stock market.